Sciensus continues to extend the full range of its services across Europe

August 13, 2024 06:32 PM AEST | By EIN Presswire

Google News:

Sciensus continues to extend the full range of its services across Europe — Image source: EIN Presswire

Recent News

Epiminder Announces Publication of Landmark Clinical Trial Confirming...

Grocery retailers driving ~3.8% incremental sales growth with new data...

FTSE 100 today: shares gain as U.K. GDP falls; Pound above $1.35; Tesc...

JPM: institutions, not retail, drove U.S. stock market correction

ZUG, SWITZERLAND , August 13, 2024 /EINPresswire.com/ -- Sciensus, a life sciences business, specialising in patient access, engagement and insight solutions has announced that it is extending the full range of its services to Switzerland.

The Swiss office, located in Zug and led by Managing Director, Tina Lupberger, will bolster Sciensus’ European offering by adding patient insights to the well-established support network for patients with long-term conditions, rare diseases, and cancer, to give them more control of their medicine and help them achieve better health outcomes.

Sciensus has a significant EU footprint, with offices in the Netherlands, Germany, and Switzerland, which are all now part of the drive to extend their digitally enabled real world patient insight offerings internationally.

Tens of millions of patient interactions every year are captured through advanced patient apps and digital platforms, allowing Sciensus to gather vital insight into the patient experience and the drivers of medicine adherence. Powered by these interactions, Sciensus develops and deploys innovative patient interventions and support programmes. These generate invaluable real-world insights to enable clinicians and pharmaceutical companies to deliver an elevated patient experience and better health outcomes for patients overall.

Tina Lupberger, Managing Director of Sciensus Switzerland, said: “I look forward to working with our global team to drive and deliver digital+ solutions with an all-important human touch, and providing access to medicines for our patients in the EU and beyond. Leveraging my experience of 30 years in the pharmaceutical industry, I am excited to build a world class team who will help us achieve our vision to help each and every patient make the most out of their medicine.”

Richard Blyth, Chief Marketing and Product Officer for Sciensus, said: “Tina’s experience from leading roles in renowned pharmaceutical companies, both in Switzerland and internationally, will be invaluable in helping us advance our patient outreach and engagement programmes. We look forward to working together to uncover profound insights about how patients interact with medicines in a real-world setting, enabling pharmaceutical companies and healthcare professionals to make faster, more informed decisions.”

Kasia Banas
Teneo
[email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.